Get the Stockscreener App
1.15
3.60%
0.04
Shattuck Labs Inc stock is traded at $1.15, with a volume of 111.48K.
It is up +3.60% in the last 24 hours and up +0.00% over the past month.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
See More
Previous Close:
$1.11
Open:
$1.12
24h Volume:
111.48K
Relative Volume:
0.39
Market Cap:
$54.90M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-0.5959
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
+2.68%
1M Performance:
+0.00%
6M Performance:
-73.86%
1Y Performance:
-87.25%
1-Day Range:
$1.11
$1.21
1-Week Range:
$1.06
$1.22
52-Week Range:
$0.94
$11.76
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
1.15 | 54.90M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Barclays PLC Has $189,000 Stock Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
Shattuck Labs, Inc. (NASDAQ:STTK) Shares Sold by Jane Street Group LLC - Defense World
Barclays PLC Buys 40,717 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Geode Capital Management LLC Raises Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Shattuck Labs highlights upcoming key milestones in 2025 - Yahoo Finance
Shattuck Labs gears up for DR3 antagonist trials in 2025 By Investing.com - Investing.com Australia
Shattuck Labs gears up for DR3 antagonist trials in 2025 - Investing.com
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025 - The Manila Times
Shattuck Labs Unveils 2025 Pipeline Roadmap: Key SL-325 Clinical Milestones, $90M Cash Position - StockTitan
State Street Corp Acquires 55,579 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Barfresh Food Group And 2 Other US Penny Stocks To Consider - Simply Wall St
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online
MetLife Investment Management LLC Raises Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Marketscreener.com
Shattuck Labs, Inc. (NASDAQ:STTK) Director Buys $166,713.75 in Stock - MarketBeat
Redmile Group, LLC Reduces Stake in Shattuck Labs Inc - GuruFocus.com
Shattuck Labs sees $166,713 in stock sales by Redmile Group - Investing.com
GSA Capital Partners LLP Invests $121,000 in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs to Present at Piper Sandler and Evercore Healthcare Conferences | STTK Stock News - StockTitan
Shattuck Labs Falls To US$1.01, But Insiders Sold At Lower Price - Simply Wall St
Shattuck Labs stock plunges to 52-week low at $1.06 By Investing.com - Investing.com Canada
Shattuck Labs stock plunges to 52-week low at $1.06 - Investing.com India
Citigroup Downgrades Shattuck Labs (STTK) - MSN
Shattuck Labs’ (STTK) Neutral Rating Reaffirmed at HC Wainwright - Defense World
Shattuck Labs Focuses on Promising Antibody Development - TipRanks
Shattuck Labs FY2024 EPS Forecast Decreased by HC Wainwright - MarketBeat
HC Wainwright Lowers Earnings Estimates for Shattuck Labs - Defense World
Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
STTK (Shattuck Labs) Degree of Operating Leverage : -0.01 (As of Jun. 2024) - GuruFocus.com
Shattuck Labs' (STTK) "Neutral" Rating Reiterated at HC Wainwright - MarketBeat
Shattuck Labs sees cash runway into 2027 - Yahoo Finance
Shattuck Labs Inc (STTK) Quarterly 10-Q Report - Quartz
Shattuck Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Shattuck Labs Inc (STTK) Q3 2024 Earnings: Revenue Soars to $3.0M, EPS Loss of $0.33 Beats Estimates - GuruFocus.com
Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times
Shattuck Labs Narrows Q3 Loss, Pivots Focus to SL-325 with $90.1M Cash Runway | STTK Stock News - StockTitan
Prosight Management, LP Expands Stake in Shattuck Labs Inc - GuruFocus.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc.STTK - PR Newswire
FMR LLC's Strategic Reduction in Shattuck Labs Inc Holdings - GuruFocus.com
Vanguard Group Inc's Strategic Acquisition in Shattuck Labs Inc - GuruFocus.com
Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Down 60.0% in October - Defense World
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):